AU2003280821A8 - Beauveriolide derivative - Google Patents
Beauveriolide derivativeInfo
- Publication number
- AU2003280821A8 AU2003280821A8 AU2003280821A AU2003280821A AU2003280821A8 AU 2003280821 A8 AU2003280821 A8 AU 2003280821A8 AU 2003280821 A AU2003280821 A AU 2003280821A AU 2003280821 A AU2003280821 A AU 2003280821A AU 2003280821 A8 AU2003280821 A8 AU 2003280821A8
- Authority
- AU
- Australia
- Prior art keywords
- beauveriolide
- derivative
- beauveriolide derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2003/014577 WO2005047312A1 (en) | 2003-11-17 | 2003-11-17 | Beauveriolide derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003280821A1 AU2003280821A1 (en) | 2004-06-06 |
AU2003280821A8 true AU2003280821A8 (en) | 2005-06-06 |
Family
ID=34587065
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003280821A Abandoned AU2003280821A1 (en) | 2003-11-17 | 2003-11-17 | Beauveriolide derivative |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003280821A1 (en) |
WO (1) | WO2005047312A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010126454A (en) * | 2008-11-25 | 2010-06-10 | Kitasato Institute | Beauveriolide having acat2 inhibitory activity |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002275194A (en) * | 2001-03-21 | 2002-09-25 | Kitasato Gakuen | New fo-6979-m0 substance, fo-6979-m1 substance, fo-6979-m2 substance, fo-6979-m3 substance and fo-6979-m4 substance and method for producing the same |
-
2003
- 2003-11-17 AU AU2003280821A patent/AU2003280821A1/en not_active Abandoned
- 2003-11-17 WO PCT/JP2003/014577 patent/WO2005047312A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2005047312A1 (en) | 2005-05-26 |
AU2003280821A1 (en) | 2004-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1091204A1 (en) | Heteroarylcarbamoylbenzene derivative | |
IL176562A0 (en) | Amidopyrazole derivative | |
HK1088602A1 (en) | 2-pyridinecarboxamide derivatives | |
HK1088326A1 (en) | Piperidine-benzenesulfonamide derivatives | |
HK1089443A1 (en) | Imidazol-4-yl-ethynyl-pyridine derivatives | |
GB0317665D0 (en) | Qinazoline derivatives | |
ZA200603879B (en) | Substituted indazole-O-glucosides | |
IL175490A0 (en) | Substituted indazole-o-glucosides | |
ZA200603880B (en) | Substituted indole-O-glucosides | |
PL1682493T3 (en) | Amidoacetonitrile derivatives | |
EP1680131A4 (en) | Substituted indole-o-glucosides | |
IL175189A0 (en) | N-thiazol-2-yl-benzamide derivatives | |
DE502004003476D1 (en) | Standfuss | |
ZA200600430B (en) | Substituted spirobenzazepines | |
DE502004004146D1 (en) | Pyrazolverbindungen | |
SI1706373T1 (en) | Amidoacetonitrile derivatives | |
DE112004002769D2 (en) | Schienengeführtes transportsystem | |
DE10394343D2 (en) | Berührungslose biometrische erkennung | |
GB0312368D0 (en) | Novel ureido- and amido-pyrazolone derivatives | |
GB0319793D0 (en) | Pyridinylmorpholine derivatives | |
AU2003280821A8 (en) | Beauveriolide derivative | |
TWI341309B (en) | Heteroarylcarbamoylbenzene derivatives | |
AU2833P (en) | Baltinrose Gaura lindheimeri | |
AU2834P (en) | Baltinblus Gaura lindheimeri | |
AU2003280822A8 (en) | Beauveriolide derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TH | Corrigenda |
Free format text: IN VOL 19, NO 28, PAGE(S) 1849 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME CHEMGENESIS INCORPORATED, APPLICATION NO. 2003280821, UNDER INID (43) CORRECT THE DATE TO READ 06.06.2005 |
|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |